GeneDx Holdings Corp. lost $0.73 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $3.64 per diluted share. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters GeneDx Holdings Corp. has filed alongside them.
FY2025 annual
EPS (Diluted)-$0.73
YoYn/m
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
WGS EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was GeneDx Holdings Corp.'s diluted earnings per share in fiscal year 2025?
GeneDx Holdings Corp. lost $0.73 per diluted share in fiscal year 2025.
How fast is GeneDx Holdings Corp.'s diluted earnings per share growing?
GeneDx Holdings Corp. (WGS) reported a loss of $1.94 per diluted share in fiscal year 2024 and a loss of $0.73 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is GeneDx Holdings Corp.'s diluted earnings per share over the last twelve months?
GeneDx Holdings Corp. (WGS) reported a loss of $3.64 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has GeneDx Holdings Corp.'s diluted earnings per share changed over the years?
Across the 7 fiscal years this page covers, GeneDx Holdings Corp. (WGS) diluted earnings per share went from -$264056.00 in fiscal year 2019 to -$0.73 in fiscal year 2025.
What was GeneDx Holdings Corp.'s diluted earnings per share in the most recent quarter?
GeneDx Holdings Corp. (WGS) reported -$0.60 in diluted earnings per share in Q2 2026. This represents a decrease of 266.7% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what GeneDx Holdings Corp. (WGS) reported on that line in every period on record.
